Literature DB >> 11940085

Participation rates of Ashkenazi Jews in a colon cancer community-based screening/prevention study.

M Cappelli1, A G W Hunter, H Stern, L Humphreys, L Van Houten, K O'Rourke, S Viertelhausen, H Perras, A E Lagarde.   

Abstract

In a recent colon cancer risk study, genetic assessment and colonoscopy were offered to virtually all of the adult Ashkenazi Jews in an urban community. The present study was designed to examine factors influencing participation and response in the initial study and to suggest strategies for improving participation in future health promotion programs. The study comprised a random sample of three groups of individuals who had been targeted for participation in the previous study: those who had (a) agreed to participate (n = 234); (b) declined participation (n = 179); and (c) failed to respond to a mailed recruitment package (n = 128). All participants completed a brief telephone survey. Key multivariate predictors of both response and participation were individuals' perceptions of the drawbacks of participating in colon cancer screening research and the degree of decisional conflict they experienced. Response was further predicted by the influence of spouses, family history of colon cancer, past knowledge of genetic testing for colon cancer, and education level. Participation was predicted by awareness that the study was supported by the Ashkenazi Jewish community, past experience with genetic testing, individuals' perceptions of the benefits of participating, and whether or not they had children. The degree to which individuals understand the purpose and nature of genetic screening research, along with their levels of decisional conflict and other psychosocial factors, may influence the likelihood of their participation in such research. Results of this study suggest a number of possible strategies for improving participation and response rates in disease prevention and detection studies.

Entities:  

Mesh:

Year:  2002        PMID: 11940085     DOI: 10.1034/j.1399-0004.2002.610205.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  Acceptance of flexible sigmoidoscopy as a screening examination for colorectal cancer in an outpatient clinic.

Authors:  S Gölder; W Vogt; H Lichti; H C Rath; A Kullmann; J Schölmerich; F Kullmann
Journal:  Int J Colorectal Dis       Date:  2006-07-04       Impact factor: 2.571

Review 2.  Predictors of genetic testing decisions: a systematic review and critique of the literature.

Authors:  Kate Sweeny; Arezou Ghane; Angela M Legg; Ho Phi Huynh; Sara E Andrews
Journal:  J Genet Couns       Date:  2014-04-11       Impact factor: 2.537

3.  Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD).

Authors:  M A Espeland; K Dotson; S A Jaramillo; S E Kahn; B Harrison; M Montez; J P Foreyt; B Montgomery; W C Knowler
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

4.  Should pretest genetic counselling be required for patients pursuing genomic sequencing? Results from a survey of participants in a large genomic implementation study.

Authors:  Joel E Pacyna; Carmen Radecki Breitkopf; Sarah M Jenkins; Erica J Sutton; Caroline Horrow; Iftikhar J Kullo; Richard R Sharp
Journal:  J Med Genet       Date:  2018-12-22       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.